Application of the Yamaguchi criteria for classification of “suspected” systemic juvenile idiopathic arthritis (sJIA)

[11] Noordman BJ(2008)How the study of children with rheumatic diseases identified interferon-α and interleukin-1 as novel therapeutic targets Immunol Rev 223 39-537

[12] Holzinger D(2009)Targeting interleukin-6 in pediatric rheumatic diseases Curr Opin Rheumatol 21 533-2626

[13] Prakken B(2003)Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis Arthritis Rheum 48 2622-889

[14] Wulffraat N(2009)The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1 beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis Arthritis Rheum 60 883-2793

[15] Cabane J(2009)Defective phosphorylation of interleukin-18 receptor β causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis Arthritis Rheum 60 2782-598

[16] Michon A(2007)Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study Ann Rheum Dis 66 589-2541

[17] Ziza JM(2002)Highly elevated serum levels of interleukin18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al Arthritis Rheum 46 2539-1785

[18] Bourgeois P(2001)A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis Arthritis Rheum 44 1782-237

[19] Bletry O(2002)Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis Arthritis Rheum 46 232-3931

[20] Godeau P(2008)S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin Arthritis Rheum 58 3924-971

[11] Noordman BJ(2008)How the study of children with rheumatic diseases identified interferon-α and interleukin-1 as novel therapeutic targets Immunol Rev 223 39-537

[12] Holzinger D(2009)Targeting interleukin-6 in pediatric rheumatic diseases Curr Opin Rheumatol 21 533-2626

[13] Prakken B(2003)Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis Arthritis Rheum 48 2622-889

[14] Wulffraat N(2009)The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1 beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis Arthritis Rheum 60 883-2793

[15] Cabane J(2009)Defective phosphorylation of interleukin-18 receptor β causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis Arthritis Rheum 60 2782-598

[16] Michon A(2007)Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study Ann Rheum Dis 66 589-2541

[17] Ziza JM(2002)Highly elevated serum levels of interleukin18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al Arthritis Rheum 46 2539-1785

[18] Bourgeois P(2001)A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis Arthritis Rheum 44 1782-237

[19] Bletry O(2002)Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis Arthritis Rheum 46 232-3931

[20] Godeau P(2008)S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin Arthritis Rheum 58 3924-971